Back to search

Article

Resiquimod-encapsulated MOF525 for Sustained Immunostimulant Release and Synergistic Photodynamic– Immunotherapy in Colorectal Cancer

2026-01-14

Abstract excerpt

<title>Abstract</title> <p> Metal-organic frameworks (MOFs) represent a novel class of materials with exceptional potential for biomedical applications. In this study, we present MOF525, a porphyrin-based MOF, as a dual-functional platform for photodynamic therapy (PDT) and immunotherapy in the treatment of colorectal cancer. MOF525 encapsulates Resiquimod (R848), a potent Toll-like receptor 7/8 agonist, thereby...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4a897c51-dbe7-5ede-83ca-80bb0ceccff5
DOI
10.21203/rs.3.rs-8452162/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Resiquimod-encapsulated MOF525 for Sustained Immunostimulant Release and Synergistic Photodynamic– Immunotherapy in Colorectal CancerDOI 10.21203/rs.3.rs-8452162/v1
Select a neighboring publication to make it the new centre.